Intratumoral mRNA levels predict clinical outcome in patients with metastatic colorectal cancer treated in a prospective clinical trial with 5-FU and oxaliplatin

D. Yang,Daniel Vallböhmer,Wu Zhang,Syma Iqbal,Anthony B. El-Khoueiry,M. Gordon,David J. Park,Mizutomo Azuma,Susan Groshen,Kathleen D. Danenberg,H Lenz

Intratumoral mRNA levels predict clinical outcome in patients with metastatic colorectal cancer treated in a prospective clinical trial with 5-FU and oxaliplatin

2006

D. Yang
Daniel Vallböhmer
Wu Zhang
Syma Iqbal
Anthony B. El-Khoueiry
M. Gordon
David J. Park
Mizutomo Azuma
Susan Groshen
Kathleen D. Danenberg
H Lenz

10010 Background: 5-flurouracil (5-FU) and Oxaliplatin-based therapy is one of the most frequently used combinations in the treatment of advanced colorectal cancer (CRC). There are no validated and...

Keywords:

Colorectal cancer
Clinical trial
Oncology
Cancer research
Internal medicine
Medicine
Oxaliplatin
advanced colorectal cancer
in patient
mrna level

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations